Bayer Aktiengesellschaft (BAYRY)
OTCMKTS · Delayed Price · Currency is USD
14.30
0.00 (0.00%)
Sep 9, 2026, 11:26 AM EST
Bayer Aktiengesellschaft Market Cap
Bayer Aktiengesellschaft has a market cap or net worth of $56.51 billion as of September 9, 2026. Its market cap has increased by 73.31% in one year.
Market Cap
56.51B
Enterprise Value
95.41B
Revenue
51.84B
Ranking
n/a
PE Ratio
n/a
Stock Price
$14.30
ChartMarket Cap Chart
Since January 1, 1992, Bayer Aktiengesellschaft's market cap has increased from 5.86B to 56.51B, an increase of 864.41%. That is a compound annual growth rate of 6.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 56.51B | 32.13% |
| Dec 30, 2025 | 42.77B | 117.25% |
| Dec 30, 2024 | 19.69B | -46.09% |
| Dec 29, 2023 | 36.52B | -28.02% |
| Dec 30, 2022 | 50.74B | -2.95% |
| Dec 30, 2021 | 52.28B | -10.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 878.45M |
| Veradigm | 819.08M |
| Nika Pharmaceuticals | 431.19M |
| American Oncology Network | 336.99M |
| Northwest Biotherapeutics | 289.36M |
| Elite Pharmaceuticals | 277.90M |
| CytoDyn | 275.42M |
| Glorywin Entertainment Group | 234.77M |